Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Deborah A. Mulford

Nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

Frontiers in Oncology
Cancer ResearchOncology
2018English

Rapid Method for Detection of Mutations in the Nucleophosmin Gene in Acute Myeloid Leukemia

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2008English

Related publications

P2.01-014 ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients With NSCLC and ECOG PS 2

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

P1.16-21 Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients With Locally Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

216PD: Nab-Paclitaxel + Carboplatin (Nab-P/C) in Advanced Non-Small Cell Lung Cancer (NSCLC): Outcomes in Elderly Patients (Pts) With Squamous (SCC) Histology

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

P1.01-70 Efficacy and Safety of Second- Or Third-Line Nab-Paclitaxel + Durvalumab in Patients With Advanced NSCLC (ABOUND.2L+)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.01-93 Quality of Life in Patients With Advanced NSCLC Treated in Second- Or Third-Line With Nab-Paclitaxel + Durvalumab: ABOUND.2L+

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nab-Paclitaxel/Carboplatin Induction in Squamous NSCLC: Longitudinal Quality of Life While on Chemotherapy

Lung Cancer: Targets and Therapy
Oncology
2017English

Performance Status Dynamics During Treatment With Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer

Cancer Management and Research
Oncology
2018English

Comparative Effectiveness of Early-Line Nab-Paclitaxel vs. Paclitaxel in Patients With Metastatic Breast Cancer: A US Community-Based Real-World Analysis

Cancer Management and Research
Oncology
2018English

P1.01-48 Nab-Paclitaxel Plus Gemcitabine in Advanced NSCLC After Platinum-Based Chemotherapy: Final Results and Caveolin-1 Expression

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy